METHOD OF PERSONALIZED INTRA-ARTERIAL CHEMOTHERAPEUTIC AGENT INFUSION DURING TREATMENT OF SQUAMOUS CELL CARCINOMA OF HEAD AND NECK Russian patent published in 2017 - IPC A61B5/00 A61K31/282 A61K31/513 A61P35/00 

FIELD: medicine.

SUBSTANCE: dominant vessel supplying the tumour is identified. Its selective catheterization is performed, and volumetric blood flow rate is determined. Platinum drug is administered at a rate equal to or exceeding the volumetric blood flow rate by max. 16.7%. The administered drug volume is calculated from the ratio of 75-100 mg/m² of the patient body surface area. Then, 5-fluorouracil is administered in the same vessel, at an infusion rate equal to or exceeding the vessel volumetric blood flow rate by max. 16.7% in a volume of 250 ml.

EFFECT: method can reduce the severity of toxic reactions to chemotherapy, eliminate complications and deaths related to the treatment itself, eliminate the pathological changes in kidney function and improve the overall one-year survival rates to 94 percent.